EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Renhuang Pharmaceutical, Inc. (the “Registrant”) on Form 10-K for the Year ended October 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Li Shaoming, chief executive officer and president of the Registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Dated:  January 29, 2010	/s/ Li Shaoming
	Li Shaoming
	Chief Executive Officer and President

In connection with the Annual Report of Renhuang Pharmaceutical, Inc. (the “Registrant”) on Form 10-Kfor the Year ended October 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yan Yi Chen, chief financial officer of the Registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Dated:  January 29, 2010	/s/ Yan Yi Chen
	Yan Yi Chen
	Chief Financial Officer